Endocrinology Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Endocrinology Tests Pipeline Market Report Overview
Endocrinology tests are the reagents used for quantification and detection of endocrine hormones secreted in the human body. The endocrinology tests pipeline market research report provides comprehensive information about the endocrinology tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress.
Key Segments | · Growth Hormone (GH) Function Tests
· Individual and Specified Hormones · Bone Metabolism Assays · Adrenocorticotropic Hormone (ACTH) Function Tests · 25-OH Vitamin D Tests · Parathyroid Hormone (PTH) Tests · Calcitonin Tests |
Key Territories | · The United States
· China · Europe · Australia · Singapore · India · Japan · South Korea |
Key Regulatory Paths | · 510(k)
· NMPA · CE-IVD · TGA · HSA · ICAC · Ninsho · MDITAC · CLIA · BLA · CE |
Leading Companies | · AMS Diagnostics LLC
· Beckman Coulter Inc · Celmatix Inc · Denka Seiken Co Ltd · DiaSorin SpA · EDP Biotech Corporation |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Endocrinology Tests Pipeline Market by Segments
The key segments in the endocrinology tests pipeline market are Growth Hormone (GH) Function Tests, Individual and Specified Hormones, Bone Metabolism Assays, Adrenocorticotropic Hormone (ACTH) Function Tests, 25-OH Vitamin D Tests, Parathyroid Hormone (PTH) Tests, and Calcitonin Tests. As of September 2023, Growth Hormone (GH) Function Tests have a higher number of pipeline products.
Endocrinology Tests Pipeline Market Analysis by Segments, 2023 (%)
Buy the Full Report for More Segment Insights into the Endocrinology tests Pipeline Market
Endocrinology Tests Pipeline Market Segmentation by Territories
Some of the key territories in the endocrinology tests market are the United States, China, Europe, Australia, Singapore, India, Japan, and South Korea. As of September 2023, the global market besides the above-mentioned countries has the highest number of pipeline products.
Endocrinology Tests Pipeline Market Analysis by Territories, 2023 (%)
Buy the Full Report for More Territory Insights into the Endocrinology Tests Pipeline Market
Endocrinology Tests Pipeline Market Segmentation by Regulatory Paths
Some of the key regulatory paths in the endocrinology tests pipeline market are 510(k), NMPA, CE-IVD, TGA, HSA, ICAC, Ninsho, MDITAC, CLIA, BLA, and CE. As of September 2023, 510(k) is the most followed pathway for pipeline products in the market.
Endocrinology Tests Pipeline Market Analysis by Regulatory Paths, 2023 (%)
Buy the Full Report for More Regulatory Path Insights into the Endocrinology Tests Pipeline Market
Download A Free Report Sample
Endocrinology Tests Pipeline Market – Competitive Landscape
Some of the key companies in the endocrinology tests pipeline market are AMS Diagnostics LLC, Beckman Coulter Inc, Celmatix Inc, Columbia University, Denka Seiken Co Ltd, DiaSorin SpA, and DIANA Biotechnologies SRO among others.
Celmatix Inc: Celmatix Inc (Celmatix) discovers and develops women’s health therapeutics. The company’s lead program ovarian senescence provides chemotherapy-induced ovarian failure for women with mosaic turner syndrome, primary ovarian insufficiency, endometriosis, and polycystic ovary syndrome.
DiaSorin SpA: DiaSorin SpA (DiaSorin) is a medical diagnostics company that is engaged in the development, manufacturing, and marketing of in vitro diagnostics reagent kits and systems. The company develops reagent kits based on Enzyme-Linked Immunosorbent Assays (ELISA) and Chemiluminescence (CLIA) techniques, to enable automatic diagnostic investigation.
Endocrinology Tests Pipeline Market Analysis by Companies, 2023
Buy the Full Report for More Company Insights into the Endocrinology Tests Pipeline Market
Download A Free Report Sample
Segments Covered in the Report
Endocrinology Tests Pipeline Market Segments Outlook
- Growth Hormone (GH) Function Tests
- Individual and Specified Hormones
- Bone Metabolism Assays
- Adrenocorticotropic Hormone (ACTH) Function Tests
- 25-OH Vitamin D Tests
- Parathyroid Hormone (PTH) Tests
- Calcitonin Tests
Endocrinology Tests Pipeline Market Territories Outlook
- The United States
- China
- Europe
- Australia
- Singapore
- India
- Japan
- South Korea
Endocrinology Tests Pipeline Market Regulatory Paths Outlook
- 510(k)
- NMPA
- CE-IVD
- TGA
- HSA
- ICAC
- Ninsho
- MDITAC
- CLIA
- BLA
- CE
Scope
This report provides:
- Extensive coverage of the endocrinology tests under development.
- Details of major pipeline products which include product description, licensing and collaboration details and other developmental activities.
- Reviews of major players involved in the development of endocrinology tests and lists all their pipeline projects.
- Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.
- Provides key clinical trial data related to ongoing clinical trials specific to pipeline products.
- Recent developments in the segment/industry.
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies.
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Identify and understand important and diverse types of endocrinology tests under development.
- Develop market-entry and market-expansion strategies.
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date.
AMS Diagnostics LLC
Axis-Shield Diagnostics Ltd
Beckman Coulter Inc
Carolina Liquid Chemistries Corp
Celmatix Inc
Ceres Nanosciences Inc
Columbia University
Denka Seiken Co Ltd
DIANA Biotechnologies SRO
DiaSorin SpA
EDP Biotech Corporation
G Medical Health and Wellness
Guangzhou Wondfo Biotech Co Ltd
Hansjorg Wyss Institute for Biologically Inspired Engineering
I-Mab Biopharma Co Ltd
Intelligent Bio Solutions Inc
Laboratoire HRA Pharma SAS
MDNA Life Sciences Inc
MyHealthTest Pty Ltd
Revvity Inc
Roche Diagnostics International Ltd
Sendera Discovery
Shenzhen Mindray Bio-Medical Electronics Co Ltd
Siemens Healthcare Diagnostics Inc
Solvd Health
Thermo Fisher Scientific Inc
Tosoh Bioscience Inc
University of California San Francisco
Table of Contents
Table
Figures
Frequently asked questions
-
Which is the leading segment in the endocrinology tests pipeline market?
Growth Hormone (GH) Function Tests are the leading segment in the endocrinology tests pipeline market as of September 2023.
-
Which territory has the highest number of products in the endocrinology tests pipeline market?
As of September 2023, the United States has the highest number of products in the endocrinology tests pipeline market.
-
Which is the most followed regulatory pathway in the endocrinology tests pipeline market?
As of September 2023, 510(k) is the most followed pathway for pipeline products in the endocrinology tests market.
-
Who are the major companies operating in the endocrinology tests pipeline market?
Some of the key companies in the endocrinology tests pipeline market are AMS Diagnostics LLC, Beckman Coulter Inc, Celmatix Inc, Columbia University, Denka Seiken Co Ltd, DiaSorin SpA, and DIANA Biotechnologies SRO.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.